Administer midazolam as pre-medication, start remifentanil TCI at 2 ng/ml, then propofol TCI at 4 μg/ml. If LOC not achieved within 1 minute, increase propofol by 0.5 μg/ml every 30 seconds. Administer muscle relaxant for ETT placement.
Maintain remifentanil TCI at ≥3 ng/ml if BP >100/60, otherwise at 2 ng/ml. Adjust propofol TCI between 2.5–6 μg/ml and remifentanil between 1–8 ng/ml based on clinical responses. Increase remifentanil when surgical stimulation is expected.
Administer appropriate analgesic towards end of surgery. Maintain propofol TCI during skin closure, stopping once final sutures are applied. Aim for remifentanil concentration of 1 ng/ml at end of dressing. Reverse paralysis if neuromuscular blockers were used.
Consider regional techniques/local infiltration. Administer morphine 0.05-0.1 mg/kg early or at least one hour before end of surgery. Consider parecoxib, ketorolac or paracetamol before surgery ends. For severe recovery room pain, use fentanyl or morphine boluses.
Even with comprehensive TIVA protocols, several critical considerations must be addressed to ensure patient safety and optimal outcomes.
Allergy to propofol or remifentanil components, including soy or egg products.
Use BIS or Entropy monitoring to prevent intraoperative awareness.
Have backup delivery systems ready if TCI pump malfunctions occur.
Treat hypotension with fluid boluses or vasopressors as needed.
Always perform a thorough pre-anesthetic assessment to identify patients at high risk for TIVA complications.

Determine patient characteristics (age, weight, comorbidities)
Select appropriate target-controlled infusion (TCI) model
Set initial target plasma and effect-site concentrations
Titrate infusion rates to achieve desired clinical effect
Monitor depth of anesthesia, blood pressure, and hemodynamic stability and adjust as needed
Check TCI pump function and battery. Verify drug labels and concentrations match programmed values.
Confirm weight, age, height, and ASA status are correctly entered.
Use standard concentrations: propofol 10mg/ml and remifentanil 50μg/ml. Double-check all calculations.
Establish BIS monitoring before induction. Ensure baseline vitals are documented.
Have vasopressors readily available. Know how to transition to alternative anesthesia if needed.

Target Controlled Infusion pumps with power cables, drug-filled syringes with perfusor tubings, and dedicated IV line or non-return valves with two three-way taps connected to patient's IV cannula.
Propofol 1% (10 mg/ml) & remifentanil (50 µg/ml). For remifentanil, add 4 mls NaCl to a 5 mg vial, take 2 mls & dilute to 50 mls with NaCl (50 µg/ml).
For propofol, use Schnider or Marsh Model (enter Age, Weight, Height and Sex). For remifentanil, use Minto model, plasma or effect-site concentration.
Ensure no leakages and that patient's IV cannula is always visible. Check infusion lines every 15 minutes. No other drugs should be administered via the TCI infusion line unless absolutely necessary.
Select the appropriate TCI model based on patient characteristics, surgical requirements, and institution protocols. Personalize target concentrations based on individual response and monitoring.
General Considerations for TIVA